N
SRGA

Nuveen’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Nuveen’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,407
Closed -$177K – 3436
2021
Q3 		$177K Hold
5,407
– – ﹤0.01% 3287
2021
Q2 		$225K Sell
5,407
-10,559
-66% -$541K ﹤0.01% 3239
2021
Q1 		$1.04M Buy
15,966
+4,078
+34% +$285K ﹤0.01% 2870
2020
Q4 		$781K Buy
11,888
+941
+9% +$61.4K ﹤0.01% 2894
2020
Q3 		$594K Buy
10,947
+1,169
+12% +$89.4K ﹤0.01% 2893
2020
Q2 		$933K Buy
9,778
+1,342
+16% +$100K ﹤0.01% 2643
2020
Q1 		$433K Sell
8,436
-690
-8% -$72.1K ﹤0.01% 2819
2019
Q4 		$750K Hold
9,126
– – ﹤0.01% 2789
2019
Q3 		$780K Sell
9,126
-427
-4% -$45.6K ﹤0.01% 2794
2019
Q2 		$1.22M Buy
+9,553
New +$1.38M ﹤0.01% 2654

Other funds holding SRGA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Nuveen's SRGA Position: Q4 2021 in Review

Nuveen sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 5,407 shares — an estimated $177K sold.

Nuveen first reported a position in SRGA in Q2 2019 and held it in 10 quarters. The position peaked at $1.22M in Q2 2019. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.

  • Nuveen reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Nuveen sold 5,407 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $177K.
  • Nuveen first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • Nuveen's Surgalign Holdings, Inc. Common Stock position peaked at $1.22M in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.